Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2000 Oct;76(5):366–370. doi: 10.1136/sti.76.5.366

Prevalence of HTLV infection in pregnant women in Spain

A Machuca 1, C Tuset 1, V Soriano 1, E Caballero 1, A Aguilera 1, R O de Lejarazu 1
PMCID: PMC1744220  PMID: 11141853

Abstract

Objective: To estimate the prevalence of HTLV infection among pregnant women in Spain.

Methods: A commercial ELISA incorporating HTLV-I and HTLV-II antigens was used for HTLV antibody screening. Repeatedly reactive samples were further examined by western blot. Moreover, confirmation with PCR was performed when cells were available.

Results: 20 366 pregnant women in 12 different Spanish cities were tested in a 3 year period (July 1996 to August 1999). 32 samples were repeatedly reactive by ELISA, and 10 of them were confirmed as positive by western blot (eight for HTLV-II and two for HTLV-I). In addition, three of 13 women who had an indeterminate western blot pattern yielded positive results for HTLV-II by PCR. All 11 HTLV-II infected women had been born in Spain, and all but one were former drug users. Seven of them were coinfected with HIV-1. One HTLV-I infected woman was from Peru, where HTLV is endemic and where she most probably was infected during sexual intercourse.

Conclusion: The overall prevalence of HTLV infection among pregnant women in Spain is 0.064% (13/20 366), and HTLV-II instead of HTLV-I is the most commonly found variant. A strong relation was found among HTLV-II infection and specific epidemiological features, such as Spanish nationality and injecting drug use. Although HTLV-II can be vertically transmitted, mainly through breast feeding, both the low prevalence of infection and its lack of pathogenicity would not support the introduction of HTLV antenatal screening in Spain.

Key Words: HTLV; pregnant women; adult T cell leukaemia/lymphoma; tropical spastic paraparesis; epidemiology

Full Text

The Full Text of this article is available as a PDF (130.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Courtois F., Barin F., Larsen M., Brossard Y., Masselin A., Engelman P. HTLV-I/II infection in pregnant women in Paris. Lancet. 1990 May 5;335(8697):1103–1103. doi: 10.1016/0140-6736(90)92681-7. [DOI] [PubMed] [Google Scholar]
  2. Froment A., Delaporte E., Dazza M. C., Larouzé B. HTLV-II among pygmies from Cameroon. AIDS Res Hum Retroviruses. 1993 Aug;9(8):707–707. doi: 10.1089/aid.1993.9.707. [DOI] [PubMed] [Google Scholar]
  3. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  4. Hale A., Leung T., Sivasubramaniam S., Kenny J., Sutherland S. Prevalence of antibodies to HTLV in antenatal clinic attenders in south east London. J Med Virol. 1997 Jul;52(3):326–329. [PubMed] [Google Scholar]
  5. Heneine W., Kaplan J. E., Gracia F., Lal R., Roberts B., Levine P. H., Reeves W. C. HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med. 1991 Feb 21;324(8):565–565. doi: 10.1056/NEJM199102213240815. [DOI] [PubMed] [Google Scholar]
  6. Hino S., Yamaguchi K., Katamine S., Sugiyama H., Amagasaki T., Kinoshita K., Yoshida Y., Doi H., Tsuji Y., Miyamoto T. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res. 1985 Jun;76(6):474–480. [PubMed] [Google Scholar]
  7. Hjelle B., Appenzeller O., Mills R., Alexander S., Torrez-Martinez N., Jahnke R., Ross G. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet. 1992 Mar 14;339(8794):645–646. doi: 10.1016/0140-6736(92)90797-7. [DOI] [PubMed] [Google Scholar]
  8. Kaplan J. E., Osame M., Kubota H., Igata A., Nishitani H., Maeda Y., Khabbaz R. F., Janssen R. S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr. 1990;3(11):1096–1101. [PubMed] [Google Scholar]
  9. Komuro A., Hayami M., Fujii H., Miyahara S., Hirayama M. Vertical transmission of adult T-cell leukaemia virus. Lancet. 1983 Jan 29;1(8318):240–240. doi: 10.1016/s0140-6736(83)92613-2. [DOI] [PubMed] [Google Scholar]
  10. Lee H., Swanson P., Shorty V. S., Zack J. A., Rosenblatt J. D., Chen I. S. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science. 1989 Apr 28;244(4903):471–475. doi: 10.1126/science.2655084. [DOI] [PubMed] [Google Scholar]
  11. Machuca A., Gutiérrez M., Soriano V. HTLV-I infection in Spain. HTLV Spanish Study Group. AIDS. 1998 Oct 1;12(14):1927–1928. [PubMed] [Google Scholar]
  12. Maloney E. M., Biggar R. J., Neel J. V., Taylor M. E., Hahn B. H., Shaw G. M., Blattner W. A. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis. 1992 Jul;166(1):100–107. doi: 10.1093/infdis/166.1.100. [DOI] [PubMed] [Google Scholar]
  13. Manns A., Wilks R. J., Murphy E. L., Haynes G., Figueroa J. P., Barnett M., Hanchard B., Blattner W. A. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992 Jul 30;51(6):886–891. doi: 10.1002/ijc.2910510609. [DOI] [PubMed] [Google Scholar]
  14. Medrano F. J., Soriano V., Calderón E. J., Rey C., Gutiérrez M., Bravo R., Leal M., González-Lahoz J., Lissen E. Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk. Eur J Clin Microbiol Infect Dis. 1997 Mar;16(3):249–252. doi: 10.1007/BF01709592. [DOI] [PubMed] [Google Scholar]
  15. Murphy E. L., Engstrom J. W., Miller K., Sacher R. A., Busch M. P., Hollingsworth C. G. HTLV-II associated myelopathy in 43-year-old woman. REDS Investigators. Lancet. 1993 Mar 20;341(8847):757–758. doi: 10.1016/0140-6736(93)90529-p. [DOI] [PubMed] [Google Scholar]
  16. Nightingale S., Orton D., Ratcliffe D., Skidmore S., Tosswill J., Desselberger U. Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England. Epidemiol Infect. 1993 Apr;110(2):379–387. doi: 10.1017/s0950268800068321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nyambi P. N., Ville Y., Louwagie J., Bedjabaga I., Glowaczower E., Peeters M., Kerouedan D., Dazza M., Larouze B., van der Groen G. Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):187–192. doi: 10.1097/00042560-199606010-00013. [DOI] [PubMed] [Google Scholar]
  18. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schwebke J., Calsyn D., Shriver K., Saxon A., Kleyn J., Oluoch-Mitchell E., Olmstead L., Fisher L. D., Krone M., Ashley R. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users. J Infect Dis. 1994 May;169(5):962–967. doi: 10.1093/infdis/169.5.962. [DOI] [PubMed] [Google Scholar]
  20. Soriano V., Gutiérrez M., González-Lahoz J. Detection of HTLV-II proviral sequences in HIV-immunosuppressed patients with HTLV indeterminate serological patterns. J Infect. 1998 Mar;36(2):243–244. doi: 10.1016/s0163-4453(98)80028-5. [DOI] [PubMed] [Google Scholar]
  21. Stuver S. O., Tachibana N., Okayama A., Shioiri S., Tsunetoshi Y., Tsuda K., Mueller N. E. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis. 1993 Jan;167(1):57–65. doi: 10.1093/infdis/167.1.57. [DOI] [PubMed] [Google Scholar]
  22. Takezaki T., Tajima K., Ito M., Ito S., Kinoshita K., Tachibana K., Matsushita Y. Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group. Leukemia. 1997 Apr;11 (Suppl 3):60–62. [PubMed] [Google Scholar]
  23. Varnier O. E., Lillo F., Alexander S. S., Forbis R. M., Present W., Lazzarin A. HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection. JAMA. 1991 Feb 6;265(5):597–597. [PubMed] [Google Scholar]
  24. Vrielink H., Zaaijer H. L., Cuypers H. T., van der Poel C. L., Woerdeman M., Lelie P. N., Winkel C., Reesink H. W. Evaluation of a new HTLV-I/II polymerase chain reaction. Vox Sang. 1997;72(3):144–147. doi: 10.1046/j.1423-0410.1997.7230144.x. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES